**Core Concept**
Pioglitazone is a thiazolidinedione (TZD) class medication used in the management of type 2 diabetes mellitus. It works by activating peroxisome proliferator-activated receptor gamma (PPARγ), which regulates glucose and lipid metabolism.

**Why the Correct Answer is Right**
Pioglitazone does not directly stimulate the insulin gene or promote carbohydrate metabolism independently of insulin. Instead, it enhances the sensitivity of peripheral tissues (such as muscles and adipose tissue) to insulin, thereby facilitating glucose uptake and improving glycemic control. This action is mediated through the activation of PPARγ, which influences gene expression involved in glucose and lipid metabolism.

**Why Each Wrong Option is Incorrect**
**Option A:** Pioglitazone indeed acts as a PPARγ agonist, making this statement true.
**Option B:** Pioglitazone is primarily metabolized in the liver through the cytochrome P450 system, specifically by CYP2C8 and CYP3A4 enzymes, making this statement correct.
**Option C:** Caution is advised when using pioglitazone in patients with heart failure, particularly those with diastolic dysfunction, due to its potential to worsen fluid retention and increase the risk of heart failure exacerbation. Therefore, this statement is not entirely false, but rather a nuance in clinical management.

**Clinical Pearl / High-Yield Fact**
Pioglitazone's mechanism of action highlights the importance of PPARγ activation in modulating glucose and lipid metabolism. This concept is crucial for understanding the therapeutic effects and potential side effects of TZD class medications.

**Correct Answer:**
✓ Correct Answer: D. It acts on insulin gene and even in absence of insulin helps in metabolism of carbohydrate